Cathie Wood Just This Biotech Bet: Reading the Signals
ARKK and ARKG are back in the biotech spotlight as Cathie Wood makes new bets after a setback in a key antisense stoc...
Learn how to pick an initial coin that helps diversify your crypto holdings while keeping risk in check.
25,081 articlesARKK and ARKG are back in the biotech spotlight as Cathie Wood makes new bets after a setback in a key antisense stoc...
What happens to crypto markets when sensational headlines collide with real-world finance? This analysis uses a ficti...
RE/MAX reports a rise in 2025 net income to $8.2 million, driven by growth outside the U.S. even as U.S. agent counts...
OpenAI has redefined its mission and governance, moving into a for-profit structure and removing safety language from...
A look at how historic American combat handguns shaped modern defense investing, from the M1911 to modular pistols ad...
A veteran diplomat weighs the odds of regime change in Iran as U.S.-led strikes escalate, warning that history in the...
Turning Point Brands stock has surged, even as a prominent fund dumped millions in TPB shares. This article breaks do...
DFCF's uninterrupted monthly payouts since 2021 have drawn retirees to a fixed-income strategy. The ETF blends high-q...
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
A 400-million-barrel release from strategic reserves triggered a swift market response. Oil prices eased, gasoline fu...
Policy makers weigh oil futures as a tool to cool prices amid Iran-related tensions. Burgum signals discussions occur...
Vanguard’s VCIT offers a steady 4.73% yield paid monthly. With rate-cut expectations rising in 2026, retirees are wei...